Home >> Signaling Pathways >> Angiogenesis

Angiogenesis(血管生成)

  1. Cat.No. 产品名称 Information
  2. GC17263 Leukadherin 1 An allosteric activator of CD11b/CD18
  3. GC14857 LFM-A13 A BTK inhibitor
  4. GC19222 Lifitegrast

    立他司特; SAR 1118; SHP-606

    An inhibitor of the LFA-1/ICAM-1 interaction
  5. GC90787 Lipid A4

    一种分支离子化阳离子脂质类物质。

  6. GC13227 LRGILS-NH2 LRGILS-NH2 是一种反向序列蛋白酶激活受体-2 (PAR-2)-失活的阴性对照,SLIGRL-NH2 是一种 PAR-2 激活肽。
  7. GC47582 Lupulone

    蛇床酮

    A beta-acid
  8. GC32724 LW6 (HIF-1α inhibitor)

    HIF-1α inhibitor; LW8

    LW6是一种缺氧诱导因子1(hypoxia inducing factor 1, HIF)抑制剂,通过降解HIF-1α有效抑制HIF-1α的积累,但不影响缺氧时HIF- 1a mRNA水平。
  9. GC36500 LXW7 LXW7 是一种八聚二硫环肽,为整合素 αvβ3 的配体,能够有效、特异性地靶作用于内皮祖细胞 (EPCs) 和内皮细胞 (ECs)。在 ECs 细胞中,LXW7 可增强 VEGFR-2 的磷酸化和 ERK1/2 的活化。
  10. GC40865 LYG-202 A synthetic flavonoid with anticancer and anti-angiogenic activities
  11. GC32055 MK-0429 (L-000845704)

    L-000845704

    MK-0429 (L-000845704) (L-000845704) 是一种具有口服活性的、有效的、选择性的非肽类泛整合素拮抗剂,对于 α 的 IC50 值为 1.6 nM、2.8 nM、0.1 nM、0.7 nM、0.5 nM 和 12.2 nM ;vβ1, αvβ3, αvβ5, αvβ6, αvβ8 and α5β1, respectively.
  12. GC19251 MK-8617 A HIF-PH1, -2, and -3 inhibitor
  13. GC14319 ML 228

    CID-46742353

    A HIF pathway activator
  14. GC13004 ML161

    ML161

    Reversible inhibitor of PAR1-mediated platelet activation
  15. GC18608 MMP-2/MMP-9 Inhibitor II

    Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Inhibitor II

    A dual inhibitor of MMP-2 and MMP-9
  16. GC18616 MMP-8 Inhibitor I

    Matrix Metalloproteinase-8 Inhibitor I

    A selective inhibitor of MMP-8
  17. GC10048 MNS

    3,4-亚甲二氧-beta-硝基苯乙烯,NSC 170724; 5-(2-Nitrovinyl)benzodioxole

    An inhibitor of Src, Syk, and platelet aggregation
  18. GC10046 Molidustat (BAY85-3934)

    BAY 85-3934

    A pan-HIF-PH inhibitor
  19. GC36661 MT-802 MT-802 is a potent PROTAC that induces Bruton's tyrosine kinase (BTK) knockdown. MT-802 recruits BTK to the cereblon E3 ubiquitin ligase complex to trigger BTK ubiquitination and degradation via the proteasome. MT-802 has potential for treatment of C481S mutant chronic lymphocytic leukemia (CLL).
  20. GC49686 N-desmethyl Regorafenib N-oxide

    瑞戈非尼杂质14

    An active metabolite of regorafenib
  21. GC62255 N-piperidine Ibrutinib hydrochloride N-piperidine Ibrutinib hydrochloride, a reversible Ibrutinib derivative, is a potent BTK inhibitor with IC50s of 51.0 and 30.7 nM for WT BTK and C481S BTK, respectively.
  22. GC44290 NAADP (sodium salt)

    Nicotinic acid adenine dinucleotide phosphate

    A secondary messenger that induces calcium mobilization

  23. GC61109 Natalizumab

    那他珠单抗

    Natalizumab是一种重组的人源化单克隆抗体,与α4β1-整联蛋白(α4β1-integrin)结合并阻断其与血管细胞粘附分子1(VCAM-1)的相互作用。Natalizumab可用于复发缓解型多发性硬化症和克罗恩氏病的研究。Natalizumab也可阻止淋巴细胞进入中枢神经系统,从而防止急性脱髓鞘复发。
  24. GC44358 Nebivolol O-β-D-Glucuronide An active metabolite of nebivolol
  25. GC91360 NM-3 NM-3是一种合成异香豆素,可以抑制血管生成。
  26. GC73434 NRX-0492 NRX-0492是一种口服有效的BTK降解剂。
  27. GC44465 NSC 12

    NSC 172285

    An FGF inhibitor
  28. GC44475 NVP-BEZ235 (hydrochloride)

    Dactolisib

    Dual inhibitor of PI3K and mTOR
  29. GC69600 NX-2127 NX-2127 是一种口服有效的 BTK 抑制剂,可诱导细胞中突变的 BTKC481S 降解。NX-2127 抑制 BTKC481S 突变体 TMD8 细胞的增殖,比 Ibrutinib 更有效。NX-2127 催化 Ikaros (IKZF1) 和 Aiolos (IKZF3) 的降解,对应的作用浓度分别为 25 nM 和 54 nM。NX-2127 刺激 T 细胞活化并增加原代人 T 细胞中 IL-2 的产生。
  30. GC49349 O-Desethyl Sildenafil

    西地那非杂质C

    A metabolite of sildenafil
  31. GC16107 Obtustatin 整合素 α1β1 抑制剂
  32. GC74342 Obtustatin triacetate Obtustatin triacetate是一种41个残基的非RGD解整合素。
  33. GC17358 Octyl-α-ketoglutarate

    α-KG octyl ester

    A cell-permeable form of α-ketoglutarate
  34. GC15199 OGT 2115 An inhibitor of heparanase
  35. GC12821 Oltipraz

    奥替普拉; RP 35972; NSC 347901

    A Nrf2 and CAR activator
  36. GC13219 ONO-4059

    GS-4059 analog

    A derivative of ONO-4059
  37. GC69630 Orbofiban acetate Orbofiban acetate是一种口服活性血小板膜糖蛋白IIb/IIIa拮抗剂,抑制血小板聚集。
  38. GC41625 Oroxylin A

    千层纸素A; Baicalein 6-methyl ether; 6-Methoxybaicalein

    A flavonoid with diverse biological activities
  39. GC36821 OSU-T315

    OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain).

  40. GN10452 Paeoniflorin

    芍药苷; Peoniflorin

    A monoterpene glycoside with diverse cellular actions
  41. GC11951 PAR 4 (1-6)

    H-甘氨酸-酪氨酸-脯氨酸-甘氨酸-谷氨酸-缬氨酸-OH

    A peptide agonist of PAR4
  42. GC62101 PAR-2-IN-1 IUN76750 is a PAR-2 signaling pathway inhibitor.
  43. GA23350 PAR-3 (1-6) amide (human) A peptide agonist of PAR1 and PAR2
  44. GC15817 PAR-4 Agonist Peptide, amide (AY-NH2)

    PAR-4-AP; AY-NH2

    PAR-4 Agonist Peptide, amide(AY-NH2) (PAR-4-AP; AY-NH2) 是一种蛋白酶激活的受体 4 (PAR-4) 激动剂,对 PAR-1 或 PAR- 均无影响2 并且其作用被 PAR-4 拮抗剂阻断。
  45. GC33599 PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA))

    PAR-4-AP TFA; AY-NH2 TFA

    PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA)) 是一种合成肽,主要用于激活蛋白酶激活受体4(PAR-4)。
  46. GC69663 Parstatin(mouse) TFA Parstatin(mouse) TFA 是具有细胞通透性的 PAR-1 凝血酶受体的肽类激动剂,是一种有效的血管生成抑制剂。
  47. GC40085 Pazopanib-d6

    培唑帕尼-d6,GW786034-d6

    An internal standard for the quantification of pazopanib
  48. GC36861 PCI 29732

    4-氨基-1-环戊基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶

    A multi-kinase inhibitor
  49. GC13812 PCI-32765 (Ibrutinib)

    伊布替尼; PCI-32765

    PCI-32765 (Ibrutinib) 是一种不可逆的选择性布鲁顿氏酪氨酸激酶 (BTK) 抑制剂,可选择性靶向其激酶结构域并通过降低其磷酸化能力来调节 BTK 下游信号传导,在无细胞试验中 IC50 为 0.5 nM 。
  50. GC12921 PCI-32765 Racemate

    1-[3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]哌啶-1-基]丙-2-烯-1-酮,PCI-32765 Racemate

    PCI-32765 Racemate (PCI-32765 Racemate) 是依鲁替尼的外消旋体。 Ibrutinib 是一种选择性的、不可逆的 Btk 抑制剂,IC50 值为 0.5 nM。
  51. GC30155 PCI-33380

    PCI-33380是布鲁顿酪氨酸激酶(BTK)的不可逆抑制剂(荧光探针)。

Items 201 to 250 of 354 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7

Set Descending Direction